| The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy MM Lauridsen, M Thiele, N Kimer, H Vilstrup Metabolic brain disease 28, 231-234, 2013 | 112 | 2013 |
| Important unresolved questions in the management of hepatic encephalopathy: An ISHEN consensus JS Bajaj, M Lauridsen, EB Tapper, A Duarte-Rojo, RS Rahimi, P Tandon, ... Official journal of the American College of Gastroenterology| ACG 115 (7 …, 2020 | 110 | 2020 |
| Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy. A comparative study of 154 patients with liver disease MM Lauridsen, P Jepsen, H Vilstrup Metabolic brain disease 26, 135-139, 2011 | 103 | 2011 |
| Cognitive dysfunction in non-alcoholic fatty liver disease—current knowledge, mechanisms and perspectives K Kjærgaard, ACD Mikkelsen, CW Wernberg, LL Grønkjær, PL Eriksen, ... Journal of Clinical Medicine 10 (4), 673, 2021 | 79 | 2021 |
| Qualifying and quantifying minimal hepatic encephalopathy MY Morgan, P Amodio, NA Cook, CD Jackson, G Kircheis, MM Lauridsen, ... Metabolic brain disease 31, 1217-1229, 2016 | 59 | 2016 |
| Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review LL Grønkjær, MM Lauridsen JHEP Reports 3 (6), 100370, 2021 | 47 | 2021 |
| A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy S Montagnese, M Lauridsen, H Vilstrup, L Zarantonello, G Lakner, ... Journal of hepatology 75 (1), 98-107, 2021 | 35 | 2021 |
| Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis MM Lauridsen, H Grønbæk, EB Næser, ST Leth, H Vilstrup Metabolic brain disease 27, 559-565, 2012 | 34 | 2012 |
| In patients with cirrhosis, driving simulator performance is associated with real-life driving MM Lauridsen, LR Thacker, MB White, A Unser, RK Sterling, RT Stravitz, ... Clinical Gastroenterology and Hepatology 14 (5), 747-752, 2016 | 33 | 2016 |
| Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests MM Lauridsen, OB Schaffalitzky de Muckadell, H Vilstrup Metabolic brain disease 30, 1187-1192, 2015 | 32 | 2015 |
| Hepatic encephalopathy treatment and its effect on driving abilities: a continental divide MM Lauridsen, JS Bajaj Journal of Hepatology 63 (1), 287-288, 2015 | 30 | 2015 |
| The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention—a pilot study MM Lauridsen, S Mikkelsen, T Svensson, J Holm, C Klüver, J Gram, ... PLoS One 12 (10), e0185412, 2017 | 24 | 2017 |
| Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness VI Chandran, CW Wernberg, MM Lauridsen, MK Skytthe, SM Bendixen, ... Hepatology 77 (2), 558-572, 2023 | 23 | 2023 |
| Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy MM Lauridsen, L Poulsen, CK Rasmussen, M Høgild, MK Nielsen, ... Metabolic brain disease 31, 267-272, 2016 | 23 | 2016 |
| Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy—current validation level and practical use MKG Hansen, K Kjærgaard, LL Eriksen, LL Grønkjær, ACD Mikkelsen, ... Metabolic Brain Disease 37 (3), 589-605, 2022 | 22 | 2022 |
| Prevalence of minimal hepatic encephalopathy in patients with liver cirrhosis: A multicenter study SJ Gairing, C Mangini, L Zarantonello, S Gioia, EJ Nielsen, S Danneberg, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 18 | 2022 |
| Diagnosing covert hepatic encephalopathy MM Lauridsen, H Vilstrup Clinical Liver Disease 5 (3), 71-74, 2015 | 14 | 2015 |
| Validation of a simple Quality‐of‐Life score for identification of minimal and prediction of overt hepatic encephalopathy MM Lauridsen, P Jepsen, CW Wernberg, OB Schaffalitzky de Muckadell, ... Hepatology communications 4 (9), 1353-1361, 2020 | 13 | 2020 |
| Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients … CW Wernberg, OB Schaffalitzky de Muckadell, H Vilstrup, M M. Lauridsen PloS One 14 (12), e0226283, 2019 | 9 | 2019 |
| Closing spontaneous portosystemic shunts in cirrhosis: does it make sense? Does it work? What does it take? W Laleman, M Praktiknjo, MM Lauridsen, L Bonne, E Vanderschueren, ... Metabolic Brain Disease 38 (5), 1717-1728, 2023 | 8 | 2023 |
Jasmohan BajajVirginia Commonwealth University and McGuire VA Medical Center在 vcu.edu 的电子邮件经过验证
